[PDF][PDF] Has access to hepatitis C virus therapy changed for patients with mental health or substance use disorders in the direct‐acting‐antiviral period?
Direct‐acting antivirals (DAA) for hepatitis C virus (HCV) became available in 2014, but the
role of mental health or substance use disorders (MH/SUD) on access to treatment is …
role of mental health or substance use disorders (MH/SUD) on access to treatment is …
Disparities in treatment with direct-acting hepatitis C virus antivirals persist among adults coinfected with HIV and hepatitis C virus in US clinics, 2010–2018
Human immunodeficiency virus (HIV) and hepatitis C virus (HCV) coinfection carries
substantial risk for all-cause mortality and liver-related morbidity and mortality, yet many …
substantial risk for all-cause mortality and liver-related morbidity and mortality, yet many …
[PDF][PDF] Direct‐acting antiviral treatment use remains low among Florida Medicaid beneficiaries with chronic hepatitis C
Medicaid prior authorization (PA) policies for treatment of hepatitis C virus (HCV) with direct‐
acting antiviral (DAA) therapy are changing. We aimed to evaluate effects of changes in PA …
acting antiviral (DAA) therapy are changing. We aimed to evaluate effects of changes in PA …
[PDF][PDF] Psychosocial obstacles to hepatitis C treatment initiation among patients in care: a hitch in the cascade of cure
PR Spradling, Y Zhong, AC Moorman… - Hepatology …, 2021 - Wiley Online Library
There are limited data examining the relationship between psychosocial factors and receipt
of direct‐acting antiviral (DAA) treatment among patients with hepatitis C in large health care …
of direct‐acting antiviral (DAA) treatment among patients with hepatitis C in large health care …
[PDF][PDF] Alcohol use and long‐term outcomes among US veterans who received direct‐acting antivirals for hepatitis C treatment
NJ Kim, M Pearson, P Vutien, F Su… - Hepatology …, 2020 - Wiley Online Library
Outcomes related to alcohol use after hepatitis C virus (HCV) treatment are unknown in the
direct‐acting antiviral (DAA) era. We assessed levels of alcohol use before and after HCV …
direct‐acting antiviral (DAA) era. We assessed levels of alcohol use before and after HCV …
Prospective multicenter study of eligibility for antiviral therapy among 4,084 US veterans with chronic hepatitis C virus infection
EJ Bini, N Bräu, S Currie, H Shen… - Official journal of the …, 2005 - journals.lww.com
BACKGROUND Many veterans may not be candidates for hepatitis C virus (HCV) treatment
due to contraindications to therapy. The aims of this study were to determine the proportion …
due to contraindications to therapy. The aims of this study were to determine the proportion …
Short article: alcohol and substance use, race, and insurance status predict nontreatment for hepatitis C virus in the era of direct acting antivirals: a retrospective study …
Objective Direct acting antivirals (DAAs) have overcome many long-standing medical
barriers to hepatitis C virus (HCV) treatment (ie host characteristics and medical …
barriers to hepatitis C virus (HCV) treatment (ie host characteristics and medical …
The Impact of Direct‐Acting Antiviral Therapy on End‐Stage Liver Disease Among Individuals with Chronic Hepatitis C and Substance Use Disorders
Background and Aims Our aim was to evaluate the impact of direct‐acting antivirals (DAAs)
on decompensated cirrhosis (DCC) and HCC in patients with chronic HCV and substance …
on decompensated cirrhosis (DCC) and HCC in patients with chronic HCV and substance …
Disparities in initiation of direct-acting antiviral agents for hepatitis C virus infection in an insured population
JL Marcus, LB Hurley, S Chamberland… - Public Health …, 2018 - journals.sagepub.com
Objectives: The cost of direct-acting antiviral agents (DAAs) for hepatitis C virus (HCV)
infection may contribute to treatment disparities. However, few data exist on factors …
infection may contribute to treatment disparities. However, few data exist on factors …
Barriers to hepatitis C treatment in the era of direct‐acting anti‐viral agents
M Lin, J Kramer, D White, Y Cao… - Alimentary …, 2017 - Wiley Online Library
Background Direct‐acting anti‐virals (DAA) are safe, effective treatment of hepatitis C virus
(HCV). Suboptimal linkage to specialists and access to DAA s are the leading barriers to …
(HCV). Suboptimal linkage to specialists and access to DAA s are the leading barriers to …